DK2116257T3 - Parenterale vaccineformuleringer og anvendelser deraf - Google Patents

Parenterale vaccineformuleringer og anvendelser deraf

Info

Publication number
DK2116257T3
DK2116257T3 DK09166586.9T DK09166586T DK2116257T3 DK 2116257 T3 DK2116257 T3 DK 2116257T3 DK 09166586 T DK09166586 T DK 09166586T DK 2116257 T3 DK2116257 T3 DK 2116257T3
Authority
DK
Denmark
Prior art keywords
applications
vaccine formulations
parenteral vaccine
parenteral
formulations
Prior art date
Application number
DK09166586.9T
Other languages
English (en)
Inventor
Nanna Kristensen Soni
Janne Uldal Rahbek
Stig Aasmul-Olsen
Lise Lund
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Priority claimed from EP01957778A external-priority patent/EP1307223B1/en
Application granted granted Critical
Publication of DK2116257T3 publication Critical patent/DK2116257T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK09166586.9T 2000-08-09 2001-08-09 Parenterale vaccineformuleringer og anvendelser deraf DK2116257T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22403700P 2000-08-09 2000-08-09
DKPA200001194 2000-08-09
EP01957778A EP1307223B1 (en) 2000-08-09 2001-08-09 Parenteral vaccine formulations and uses thereof

Publications (1)

Publication Number Publication Date
DK2116257T3 true DK2116257T3 (da) 2013-02-04

Family

ID=46150006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09166586.9T DK2116257T3 (da) 2000-08-09 2001-08-09 Parenterale vaccineformuleringer og anvendelser deraf

Country Status (2)

Country Link
US (2) US20020051794A1 (da)
DK (1) DK2116257T3 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
BRPI0503817A (pt) * 2005-09-12 2007-05-15 Cristalia Prod Quimicos Farm complexo imunogênico formado por antìgenos vacinais encapsulados por sìlica mesoporosa nanoestruturada
AU2006304725B2 (en) * 2005-10-17 2012-03-15 Novartis Ag Multiclade HIV vaccines
WO2010104883A1 (en) * 2009-03-09 2010-09-16 Molecular Express, Inc. Methods and compositions for liposomal formulation of antigens and uses thereof
CN102573883A (zh) 2009-06-12 2012-07-11 疫苗技术公司 用于促进细胞-介导的免疫应答的方法和组合物
WO2010144794A1 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
CN114010776A (zh) 2010-06-09 2022-02-08 疫苗技术股份有限公司 用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
DE102010039489A1 (de) * 2010-08-18 2012-02-23 Fresenius Medical Care Deutschland Gmbh Konzentrat
CN103648489A (zh) 2011-05-11 2014-03-19 儿童医疗中心有限公司 多抗原提呈免疫原性组合物及其方法和用途
PL395069A1 (pl) * 2011-05-31 2012-12-03 Warszawski Uniwersytet Medyczny Przeciwbólowa kompozycja farmaceutyczna do podawania doustnego
RU2537225C2 (ru) * 2012-11-14 2014-12-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства Комплексный препарат на основе аллергенов пыльцы березы и мурамилпептидов
JP6494527B2 (ja) 2013-02-07 2019-04-03 ザ チルドレンズ メディカル センター コーポレーション 肺炎球菌のコロニー形成および／または疾患からの保護を提供するタンパク質抗原
CN110665000B (zh) * 2018-07-02 2022-11-11 厦门大学 锌铝复合佐剂的制备及作为疫苗佐剂的用途
CN115724449B (zh) * 2022-11-22 2023-12-12 浙大城市学院 一种混合盐纳米铝佐剂及其制备方法和应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148121A (en) 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole inhalant complex and method of making same
US3329564A (en) 1965-06-28 1967-07-04 Parke Davis & Co Antacid preparations and means of producing the same
US3692898A (en) * 1970-11-05 1972-09-19 Sterling Drug Inc Aqueous magnesium hydroxide suspensions
DE2126957B2 (de) 1971-05-29 1977-07-07 Schettler, Hermann, Dr, East Lan sing, Mich (VStA) Verfahren zur herstellung von impfstoffen gegen gaensehepatitis
US4233288A (en) 1979-03-12 1980-11-11 Cornell John A Gum emulsified liquid package for delivering and preserving liquid content in the mouth
US4341763A (en) 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
JPS61238728A (ja) 1985-04-16 1986-10-24 Mitsui Norin Kk 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体
US6103243A (en) 1985-05-15 2000-08-15 Biotechnology Australia Pty, Ltd Oral vaccines
IL84167A (en) 1986-10-24 1991-04-15 Southern Res Inst Oral delivery of bioactive agents to and through the peyer's patch by use of microencapsulation
US5032405A (en) 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
DE4007315A1 (de) 1990-03-08 1991-09-12 Behringwerke Ag Verwendung von zink-calciumhydroxid, lecithin und pao zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen
US5443832A (en) 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
EP0484621A3 (en) 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5972336A (en) 1992-11-03 1999-10-26 Oravax Merieux Co. Urease-based vaccine against helicobacter infection
EP0690722B1 (en) 1993-03-18 2004-06-30 Cytimmune Sciences, Inc. Composition and method for reducing toxicity of biologically-active factors
GB9316745D0 (en) 1993-08-12 1993-09-29 Medeva Holdings Bv Vaccine compositions
JP3414539B2 (ja) 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
US5985312A (en) 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5985287A (en) 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6048553A (en) * 1997-03-17 2000-04-11 Macquarie Veterinary Supplies Pty Ltd Aqueous metal bicarbonate solution useful in treating inflammatory, degenerative and viral diseases
US20020068090A1 (en) 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
JP2003517452A (ja) 1999-02-05 2003-05-27 アルク−アベル・アー／エス 新規粘膜デリバリーシステム
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB0020089D0 (en) 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
CN100577804C (zh) 2000-11-16 2010-01-06 阿尔克-阿贝洛有限公司 新型变态反应原突变体
CN1668737A (zh) 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
MXPA05005528A (es) 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.

Also Published As

Publication number Publication date
US20020051794A1 (en) 2002-05-02
US7785611B2 (en) 2010-08-31
US20050244420A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
NO20024355D0 (no) Nukleosidforbindelser og anvendelser derav
PL363005A1 (pl) Szczepionki
EP1412378A4 (en) APTAMERS AND ANTIAPTAMERS
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DE50112013D1 (de) Deodorantien und antiperspirantien
NO20026175L (no) Vaksinesammensetning
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DK1278763T3 (da) 3-Nitrogen-6,7-dioxygensteroider og anvendelser relateret dertil
DK2325317T3 (da) Receptornukleinsyrer og polypeptidr
NO20025656L (no) Opplöselige CTLA4 mutantmolekyler og anvendelser derav
NO20040125L (no) Enterale formuleringer
DK1317485T3 (da) Myostatin-antagonister og anvendelser deraf
IS7297A (is) Streptococcis Pneumoniae bóluefni
FR14C0016I2 (fr) Vacccin west nile
NO20031705D0 (no) Vaksiner
DE50209528D1 (de) Einzugs- und Pflückeinrichtung
DK1429769T3 (da) Nye formuleringer og anvendelse deraf
DE50105934D1 (de) Einzugs- und Pflückeinrichtung
DK2116257T3 (da) Parenterale vaccineformuleringer og anvendelser deraf
NO20025158L (no) Lipidpreparat og anvendelse derav
NO20021786L (no) Skumdempningsfremgangsmåter og sammensetninger
EP1345623A4 (en) IMMUNOGENE PROTEOLIPOSOME AND ITS USE
DE60105565D1 (de) Stabiles und wirksames weiches feststoffprodukt
NO20042693L (no) Kateterpreparat og anvendelser derav